
The companies that take GenAI from experimental to enterprise-ready will gain a competitive edge in the 2024 market. Yet many business leaders hesitate to adopt this explosive technology because of risks like hallucination and unexplainability.
A report from Enterprise Strategy Group examines today’s landscape, including the opportunities for businesses that invest in GenAI. The analyst covers:
Don’t wait for your competition to outpace you with GenAI. See what the analyst names “the strongest grounding option.”